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Background/aim: Physical exercise is a state of physiological stress that requires adaptation of the organism to physical activity.
Glycogen is an important and essential energy source for muscle contraction. Skeletal muscle and liver are two important glycogen
stores, and the energy required to maintain exercise in rodents are provided by destruction of this glycogen depot. In this study, the
effects of endogenous opioid peptide antagonism at the central nervous system level on tissue glycogen content after exhaustive exercise
were investigated.
Materials and methods: Rats had intracerebroventricularly (icv) received nonspecific opioid peptide receptor antagonist, naloxone
(50 μg/10 μL in saline) and δ-opioid receptor-selective antagonist naltrindole (50 μg/10 μL in saline) and then exercised till exhaustion.
After exhaustion, skeletal muscle, heart, and liver were excised immediately.
Results: Both opioid peptide antagonists decreased glycogen levels in skeletal muscle. Although, in soleus muscle, this decrease was
not statistically significant (p > 0.05), in gastrocnemius muscle, it was significant in the icv naloxone administered group compared
with control (p < 0.05). Heart glycogen levels increased significantly in both naloxone and naltrindole groups compared to control and
sham-operated groups (p < 0.05). Heart glycogen levels were higher in the naloxone group than naltrindole (p < 0.05). Liver glycogen
levels were elevated significantly with icv naloxone administration compared with the control group (p < 0.05). Glycogen levels in the
naloxone group was also significantly higher than the naltrindole group (p < 0.05).
Conclusion: Our findings indicate that icv administered opioid peptide antagonists may play a role in glycogen metabolism in peripheral
tissues such as skeletal muscle, heart, and liver.
Keywords: Exercise, glycogen, endogenous opioid peptide, naloxone, naltrindole

1. Introduction
Physical exercise is a state of physiological stress that
requires adaptation of the organism to physical activity.
Exercise causes an increase in heart rate, blood pressure,
tidal volume, and respiratory capacity but also affects the
levels of various hormones and metabolites [1].
Glycogen is an important and essential energy source
for muscle contraction. Skeletal muscle and liver are two
important glycogen stores [2], and the energy required to
maintain exercise in rodents is provided by destruction
of this glycogen storage. Although muscle glycogen is the
biggest source of carbohydrates during exercise, the ratio of
destruction depends on the severity of exercise [3]. When
the duration of an exercise at a certain severity is prolonged, a
decrease in glycogen level occurs [4]. Various hormonal and
central factors can affect the depletion of muscle glycogen
depots during exercise [5,6,7]. Exercise is perceived by the

organism as a stress factor [8]. It is known to increase the
secretion of endogenous opioid peptides (EOPs) such as
β-endorphins, as well as many stress hormones [9].
Endorphins are released from the anterior pituitary
gland with adrenocorticotropic hormone (ACTH) in
response to stress and in direct proportion to the severity
of exercise [10,11]. EOPs are thought to play an important
role in the regulation of hormonal and metabolic responses
to exercise. It has been shown that increased serum
β-endorphin concentration due to exercise can be associated
with various psychological and physiological changes in,
such as, mood, perception of pain, hormone levels like
ACTH, growth hormone, prolactin, catecholamines, and
cortisol, and menstrual irregularities in female athletes
[12,13].
Endogenous opioid peptides, especially β-endorphins,
have been shown to facilitate muscle glucose uptake
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during exercise [14]. Although there is no evidence that
EOPs have a direct effect on glycogen metabolism, they
can be expected to be effective on glycogen metabolism
by seriously affecting glucose uptake. Endogenous opioid
peptide receptors are known to be widely distributed in
areas related to glucose homeostases, such as the pancreas
and pituitary gland [15]. Although there are studies, which
show that centrally administered morphine and similar
compounds may affect glycogen levels in peripheral tissues
such as liver [16], there is no study showing how central
opioid peptide receptor antagonism affects glycogen levels
in peripheral tissues in relation to exercise.
As is known, physiological events and diseases that
disrupt the regulation of central opioid release could also
affect glycogen metabolism. Therefore, it is necessary
to clarify the effects of central opioid peptides (OPs) on
glycogen levels in peripheral tissues. Thus, in this study, we
aimed to investigate the effects of intracerebroventricularly
administered opioid peptide receptor antagonists on
glycogen levels in peripheral tissues such as skeletal
muscle, heart, and liver after exhausting exercise in rats.
2. Materials and methods
In this study, forty Wistar albino male rats with an average
weight of 210 g were used. The rats were fed with standard
chow and tap water ad libitum and lived at 12:12 hr lightdark cycle with room temperature at 21 °C as standard
animal care condition. According to administrations,
rats were divided into five groups as Control (C, n = 8),
Sham (Sh, n = 8), Saline (S, n = 8), Naloxone (NX, n =
8), and Naltrindole (NT, n = 8). In all groups, rats had
an exhausting exercise. Among the subjects, those who
were injured or refused to run and those who couldn’t
tolerate isoflurane sedation were excluded. This study
was approved by Gazi University Ethical Committee for
Experimental Research on Animals.
Preliminary studies were carried out for the subjects
to familiarize the treadmill. All subjects were exercised on
the treadmill for a total of 10 min/day for five consecutive
days before performing stereotaxic surgery. In this period
the speed was 7 m/min and 10 m/min in the first two days
then progressively increased to 20 m/min, the angle was
always 15° till the familiarization period.
Except for the control group, guide cannulas were
placed in the left lateral cerebral ventricles of all animals
for icv administrations. For this purpose, the subjects were
anesthetized with alphazyn (10 mg/kg) and ketamine (90
mg/kg) mixture and then placed in a stereotaxic apparatus.
The coordinates for icv application were determined as
Anterioposterior (A): –0.8 mm, Lateral (L): –1.5 mm and,
Dorsoventral (DV): –3.8 mm using the rat brain atlas
[17] and referring to the junction point of the lambda
and bregma point on the skull. The coordinates were also
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determined with preliminary experiments and confirmed
by methylene blue (Figure) and histological sections.
Rats in all groups were sedated 90 min before the
exhaustive exercise with isoflurane inhalation. Using a
Hamilton injector, 10 μL saline, 50 μg / 10 μL naloxone
(Sigma Aldrich, Germany) and 50 μg /10 μL naltrindole
(Sigma Aldrich, Germany) were intracerebroventricularly
administered to the subjects in saline, naloxone, and
naltrindole groups, respectively.
Rats were subjected to exercise until they were
exhausted on a treadmill at 20 m/ min speed and 15° incline.
When the subjects refused to run and remained in the
supine position for more than 10 s, they were determined
as “exhausted”. Blood samples were collected from the
heart of rats that were lightly sedated with isoflurane
immediately after exhaustion. Rats were decapitated after
cervical dislocation, and rapidly all tissues were excised
and frozen in liquid nitrogen, stored in a –80 °C freezer for
glycogen determination.
Tissue glycogen levels were measured according to the
method of Lo S et al. [18]. Tissue samples weighing 0.3
gr. were placed in test tubes and then 1.5 mL 30% KOH
(Merck) saturated with Na2SO4 (Merck) was added. The
tubes were boiled in a boiling water bath for 30 min until
a homogeneous solution was obtained, then cooled on ice.
An equal volume (1.5 mL) of 96% ethanol with the KOH
was added. Tissues were kept on ice for 30 min and then
centrifuged at 2400 rpm for 30 min. Supernatants were
discarded; the remaining pellets were dissolved in each of
3 mL distilled water. The sample in each tube was mixed
with a glass rod for an equal time to dissolve the glycogen
in the pellets. 1 mL of this mixture was taken and 1 mL
of phenol (Fluka, Germany) and 5 mL of 96-98% H2SO4
(Merck) were added to them. 1 mL phenol and 5 mL 96%–
98% H2SO4 were added on standard tubes containing 1 mL
of distilled water and 5 mg/mL glycogen standard (Sigma
Aldrich, Germany). Samples in all tubes were vortexed
and incubated for 10 min at room temperature. After the
incubation, the tubes were kept in a water bath set at 30 °C

Figure. Verification of intracerebroventricular coordinates with
methylene blue application.
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for 20 min. 300 μL samples taken from each tube were placed
in a 96-well plate and were read spectrophotometrically at
490 nm against standard and blank. The absorbance of the
samples was expressed as mg glycogen / g tissue.
2.1. Statistical analysis
Data analysis was performed using the Statistical Package
for Social Sciences v.23.0 (IBM Corp., Armonk, NY, USA).
Kruskal–Wallis test was used whether there was any
difference between the treatments in terms of glycogen
level in soleus, gastrocnemius, cardiac, and liver tissues.
Bonferroni correction was used for the determination of
where the difference originated. Whether there is a difference
between administrations in each group, it was compared
with Mann–Whitney U Test. Values were expressed as
mean ± standard deviation (SD), standard error of the
mean (SEM), and median (minimum, maximum), and p
values <0.05 were considered as statistically significant.
The effect size in calculating the sample size is 0.60, the
type I error was taken as 0.05 and the power value as 0.80.
3. Results
3.1. Soleus muscle glycogen level
The soleus muscle glycogen levels of rats after exhausting
exercise are shown in Table 1 as mean ± SD and SEM, also,
in Table 2, as median (min, max). When the soleus muscle
glycogen levels were compared in terms of administrations,
no statistically significant difference was observed between
the groups (p > 0.05).
3.2. Gastrocnemius muscle glycogen level
The gastrocnemius muscle glycogen levels of the rats after
exhausting exercise are shown in Table 1 as mean ± SD
and SEM, also, in Table 2, as median (min, max). When
the gastrocnemius muscle glycogen levels were compared,
in naloxone group, there was a statistically significant
decrease compared to the control (p = 0.045).

3.3.Cardiac tissue glycogen level
The heart tissue glycogen levels of the rats after exhausting
exercise are shown in Table 1 as mean ± SD and SEM,
also, in Table 2, as median (min, max). When the groups
were compared in terms of cardiac glycogen levels, there
were significant increases in naloxone and naltrindole
groups compared to control and sham groups (p =
0.006 and p = 0.003, respectively). When naloxone and
naltrindole treated groups were compared, cardiac tissue
glycogen levels in naloxone treated group was found to be
statistically significantly higher than naltrindole treated
group (p = 0.002).
3.4. Liver glycogen level
The liver tissue glycogen levels of the rats after exhausting
exercise are shown in Table 1 as mean ± SD and SEM, also,
in Table 2, as median (min, max). The glycogen level was
found to be statistically significantly higher in the naloxone
group compared to the control group (p = 0.045). When
the groups treated with naloxone and naltrindole were
compared, liver tissue glycogen levels were found to be
statistically significantly higher in the group treated with
naloxone compared to the group treated with naltrindole
(p = 0.028).
4. Discussion
In our study, we aimed to investigate the effects of central
opioid peptide receptor antagonism on skeletal muscles
such as soleus and gastrocnemius as well as heart and liver
tissues after exhaustive exercise.
Opioid peptides are known to play a role in controlling
blood glucose levels during rest and exercise. Circulating
levels of β-endorphins, an important component of the
opioid system, have been shown to increase with sufficient
intensity and time of exercise [19]. There are many studies
in the literature showing that β-endorphins and opioid
peptide antagonists can be applied by different methods

Table 1. Mean, standard deviation, and standard error of the mean values of glycogen levels in soleus, gastrocnemius,
cardiac, and liver tissue samples of rats after exhaustive exercise.

Gr

Soleus

Gastrocnemius

Cardiac

Liver

Mean ± SD

SEM

Mean ± SD

SEM

Mean ± SD

SEM

Mean ± SD

SEM

C

0.70 ± 0.52

0.23

1.16 ± 0.53

0.24

1.36 ± 0.11

0.05

1.88 ± 0.51

0.23

SH

1.43 ± 2.29

1.02

1.00 ± 1.07

0.48

1.36 ± 0.20

0.09

2.21 ± 0.25

0.11

S

0.88 ± 1.92

0.68

0.70 ± 0.38

0.14

2.47 ± 1.00

0.35

2.27 ± 0.44

0.16

NX

0.4 ± 0.44

0.18

0.60 ± 0.62

0.25

3.21 ± 0.83

0.34

2.45 ± 0.38

0.15

NT

0.91 ± 1.11

0.39

0.83 ± 0.47

0.17

2.36 ± 0.16

0.05

1.96 ± 0.28

0.10

Gr: Groups; C: Control; SH: Sham; S: Saline; NX: Naloxone; NT: Naltrindole; SD: Standard deviation; SEM: Standard
error of the mean
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Table 2. Median (minimum, maximum) values of glycogen levels in soleus, gastrocnemius, cardiac and liver tissue samples
of rats after exhaustive exercise.
Groups

Soleus median
(min, max)

Gastrocnemius median
(min, max)

Cardiac median
(min, max)

Liver median
(min, max)

C

0.90
(0.02, 1.29)

1.06
(0.60, 2.03)a

1.42
(1.23, 1.47)a,b

1.73
(1.31, 2.68)a

SH

0.82
(0.01, 5.46)

0.70
(0.27, 2.88)

1.29
(1.11, 1.61)c,d

2.14
(1.94, 2.56)

S

0.11
(0.01, 5.60)

0.62
(0.28, 1.38)

2.88
(1.17, 3.62)

2.21
(1.59, 2.90)

NX

0.34
(0.02, 1.15)

0.44
(0.14, 1.81)a

2.90
(2.72, 4.88)a,c,e

2.41
(2.04, 2.93)a,b

NT

0.44
(0.03, 3.27)

0.90
(0.26, 1.51)

2.32
(2.17, 2.59)b,d,e

1.88
(1.57, 2.54)b

p,
Kruskal Wallis Test

> 0.05

< 0.05

< 0.05

< 0.05

C-NX=0.006
C-NT=0.003
c
SH-NX=0.006
d
SH-NT=0.003
e
NX-NT=0.002
a

p,
Bonferroni correction

b
a

C-NX= 0.045

a
b

C-NX=0.045
NX-NT=0.028

C: Control; SH: Sham; S: Saline; NX: Naloxone; NT: Naltrindole
min: Minimum; max: Maximum

to investigate the role of endogenous opioid peptides in
glucose homeostasis during exercise. Hashiguchi et al.
administered intracerebroventricularly to demonstrate the
effect of central opioids on glycogen levels in peripheral
tissues as we did in the current study [16]. Radosevich et
al. practiced on dogs to demonstrate icv and iv effects of
β-endorphins on blood glucose level; they reported that
central administration had increased blood glucose levels,
whereas peripheral application did not affect glucose
homeostasis [20]. Various studies also report that these
effects of endogenous opioid peptides can be antagonized
with naloxone in experimental conditions [21].
Angelopoulos et al. demonstrated that administration of
iv naloxone antagonizes the glucagon response increasing
the effect of endogenous opioid peptides during exercise in
humans [22]. In literature, studies conducted to investigate
the central effects of opioid peptides report that applications
are generally performed as icv, and, for this purpose, guide
cannulas are placed with the stereotaxic method after the
selection of suitable coordinates. In our study, a guide
cannula was placed in the left lateral cerebral ventricle
with a similar method. We waited for a week in accordance
with the literature [16,23] for the recovery after stereotaxic
surgery. At the end of this period, glycogen levels in skeletal

2188

muscles, cardiac and liver tissues of the exhausted rats
were investigated. Glycogen is the storage form of glucose
found in most cell types and is an important and essential
energy source for muscle contraction. Skeletal muscle and
liver are the main important glycogen stores in the body as
is known [2].
In rodents, both liver and muscle glycogen is largely
used to maintain exercise. Skeletal muscles primarily use
intramuscular glycogen depots during exercise [24], as is
known.
Although muscle glycogen is the biggest source of
carbohydrates during exercise; the rate of destruction
depends on the severity of exercise [3]. Muscle glucose
uptake during exercise is also correlated with the duration
and severity of the exercise [25–27]. EOPs, especially
β-endorphins, were shown to facilitate muscle glucose
uptake during exercise [14]. Morphine is also known to
be a hormone-like effect that facilitates glucose uptake by
muscles. Morphine affects glucose uptake seriously and
also affects glycogen metabolism [28]. Physical activity
stimulates the release of β-endorphins into the circulation
[29]. A strong, nonspecific opioid antagonist naloxone is
mostly used in studies to explain the mechanisms related
to β-endorphin secretion during exercise.

İLHAN et al. / Turk J Med Sci
Both of the antagonists we used in our study reduced
glycogen levels in skeletal muscles. Although decreases
in glycogen levels are not significant in soleus muscle, in
the naloxone group, glycogen levels of the gastrocnemius
muscle were found to be significantly decreased compared
to the control group. This difference may be due to the
different types of muscle fibers.
As is known, soleus muscle is slower, and gastrocnemius
muscle has more fast-twitch muscle fibers. Evans et al. have
shown that the concentration of β-endorphin receptors
is higher in fast muscles; hence, stimulation of muscle
glucose uptake through β-endorphins in fast muscles is
greater [30]. Probably, this is the reason of why glycogen
levels in the gastrocnemius muscle are generally higher
than the soleus muscle in all groups.
A significant decrease of glycogen levels in naloxone
group of gastrocnemius muscle suggests that the effects
of β-endorphins to increase muscle glucose uptake
peripherally may be prevented by central antagonism.
Therefore, we think that present glycogen stores are spent
to supply the energy needs of the muscle. It is known that
endorphins-containing nerve cells and opioid peptide
receptors are widely distributed in nuclei of the central
nervous system, which play a role in the autonomic
regulation of the cardiovascular system [31,32]. Otherwise,
the presence of opioid receptors on autonomic targets such
as the cardiovascular system or lungs proves the presence
of direct effects of endorphins in these tissues [33].
Myocardial cells are known to have the ability to
synthesize, store and secrete opioid peptides [34]. Three
types of opioid peptides (encephalins, endorphins,
and dynorphins) are synthesized in the heart, and the
presence of preproenkephalin, prodynorphin, and
proopiomelanocortin precursor gene expressions in atrial
[35] and ventricular [35,36] cardiac myocytes are reported
in the literature.
In our study, cardiac glycogen levels in all groups
were found higher than skeletal muscle levels. This may
be related to the energy metabolism of the heart being
different from skeletal muscles. The energy required for
myocardial function during rest and exercise is provided
by glucose, fatty acids, and lactate. While all three
substrates contribute to the reconstruction of ATP at rest,
most of the energy comes from free fatty acid breakdown.
In the above-moderate exercise, lactate influx to the blood
from active skeletal muscle increases a lot, and the heart
provides most of its energy by oxidation of circulating
lactate. In prolonged submaximal exercise, the use of
free fatty acids in myocardial metabolism becomes more
prominent in supplying the total energy need [37]. This can
be the reason why cardiac tissue glycogen level is higher
than skeletal muscles in all groups. During exercise, the
energy need of the heart is likely to be obtained from other

sources, and, therefore, the use of glycogen is relatively
low. In our previous study, we obtained that blood lactate
levels after exhausting exercise were higher than preexercise levels in all groups [38]. Cardiac glycogen can be
higher than skeletal muscle levels because of the heart’s
using circulating lactate during exhausting exercise as an
energy source. When the cardiac tissue is compared in
terms of administrations, it has been observed that the
opioid peptide antagonism increases the glycogen content
of the heart. This increase was found to be significant
compared to both control and sham groups; nevertheless,
the absence of a significant difference between control
and sham groups supports that this effect is caused by
antagonist administration.
In our study, post-exercise liver glycogen levels were
also studied. Glycogen levels in naloxone group were
higher among all groups. This increase was statistically
significant when compared with the control and naltrindole
groups. Hashiguchi et al. showed that intravenously
administered morphine and its active metabolites do not
alter glycogen levels in peripheral tissues of rats, while
intracerebroventricular administered morphine reduces
liver glycogen content [16]. Researchers stated that the
cannula insertion process for icv administration led to
an acute stress response and caused significant increases
in plasma corticosterone and catecholamine levels [39].
Akil et al. also demonstrated a parallel increase in plasma
adrenocorticotropic hormone (ACTH) and β-endorphine
levels in case of stress [15]. Gunion et al. suggested that
the roles of opioids in stress response are achieved by
stimulating the pituitary-adrenal axis and μ-receptors
that activate the sympathetic nervous system [40]. It was
shown that endorphins play a role in neurotransmission
in sympathetic ganglia in central nervous system and
plexuses of the digestive system; in the periphery, it was
also shown that they are released into circulation to play
a possible hormone role by stimulation of pituitary gland
and adrenal medulla [33]. Many studies also support that
catecholamines and corticosterone can modulate the liver
glycogen content. It is reported that epinephrine induces
glycogenolysis by modulating phosphorylase activity in
the liver and skeletal muscle; corticosterone increases
glycogenolytic effects of epinephrine. Thus, hormonal
changes caused by icv opiates cause a decrease in liver
glycogen levels [16]. Since the organism perceives exercise
as a stress factor [8], plasma cortisol and catecholamine
levels increase significantly during moderate and highintensity exercise [41,42].
Our findings have shown that intracerebroventricular
opioid antagonism causes an increase in liver glycogen
levels. This increase is more significant, especially in the
naloxone group. Naloxone is known to be a nonspecific
antagonist and has a greater affinity for the μ-receptor,
although it binds to all three opioid receptors.
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In our study, although hormone levels such as
cortisol and catecholamine were not examined; we think
that activation of pituitary-adrenal axis and possible
catecholamine release induced by opioid peptides during
exercise may be prevented by centrally administered opioid
peptide antagonists. Thus, the glycogenolytic effects of
endogenous opioid peptides on the liver via the pituitaryadrenal axis and sympathetic nervous system may have
decreased relatively, and, therefore, liver glycogen levels
may remain higher in the naloxone-treated group.
As a result, our findings show that opioid peptide
antagonists administered intracerebroventricularly may
have an effect on glycogen levels in peripheral tissues
such as skeletal muscle, heart, and liver. Although there
are many studies in the literature on central opioid peptide
antagonism and exhausting exercise, no other studies have
been found on how central antagonism affects glycogen
levels in peripheral tissues after exhausting exercise.
On the other hand, since NX and NT are also inverse

agonists [43,44], the basal activity of endogenous OPR has
decreased, thus, allowing us to see the effects of OPR on
glycogen levels more clearly. However, in order to explain
the existing and possible mechanisms in more detail,
further studies are needed.
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